Re: Sensiject® Feedback Syringe

I have been in practice as a primary care Cardiologist for over 20 years and was very impressed with the new Sensiject® feedback syringe.

The ability to have a tactile awareness of the injection is a major advance in safety. The ability of disabled or visually impaired patients to safely self inject (insulin, B12, Lovenox) should increase patient acceptance.

I look forward to when all syringes have tactile feedback and medication errors can be reduced.

Sincerely yours,

Stephen A. Siegel, M.D., F.A.C.C.
Assistant Clinical Professor of Medicine
Division of Cardiology
NYU School of Medicine